Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Investing Profile

Paul Berns

InvestorVC
Managing Director at ARCH Venture Partners
ARCH Venture Partners Managing Director
$50K - $150.0M
$25.0M
15
$635.8M
CompanyStageDateRound SizeTotal Raised
Kardigan
Series AJan 2025$300M
$300M
Tenvie Therapeutics
Series AJan 2025$200M
$200M
Co-investors: Stacie Weninger (F-Prime Capital Partners), Alaa Halawa (Mubadala), Kristina Burow (ARCH Venture Partners)
Metsera
Series BNov 2024$220M
Series AApr 2024$290M
$510M
Co-investors: Kristina Burow (ARCH Venture Partners), Nimish Shah (Venrock)
Matter Neuroscience
SeedFeb 2024$26M
$26M
Co-investors: Amir Nashat (Polaris Partners)
Areteia Therapeutics
Series AFeb 2024$75M
Series AJul 2022$350M
$430M
Co-investors: Adam Koppel (Bain Capital Life Sciences)
Elephas
Series CJan 2024$55M
Series BSep 2022$42M
$97M
HI-Bio
Series BJan 2024$95M
Series ANov 2022$120M
$220M
Co-investors: Carol Suh (ARCH Venture Partners)
Happy Health
Series AAug 2022$60M
$60M